LPL Financial
BDTX icon

LPL Financial’s Black Diamond Therapeutics BDTX Stock Holding History

LPL Financial’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.5K Sell
40,795
-2,000
-5% -$4.89K ﹤0.01% 5962
2026
Q1 		$91.2K Buy
42,795
+5,805
+16% +$13.8K ﹤0.01% 5691
2025
Q4 		$89.9K Sell
36,990
-32,250
-47% -$114K ﹤0.01% 5626
2025
Q3 		$262K Sell
69,240
-13,700
-17% -$40.1K ﹤0.01% 5160
2025
Q2 		$206K Buy
82,940
+2,700
+3% +$5.2K ﹤0.01% 5068
2025
Q1 		$124K Buy
+80,240
New +$168K ﹤0.01% 4994

Other funds holding BDTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LPL Financial's BDTX Position: Q2 2026 in Review

LPL Financial reduced its Black Diamond Therapeutics (BDTX) stake by 4.7% in Q2 2026, selling an estimated $4.89K and leaving 40,795 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5962.

LPL Financial first reported a position in BDTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $262K in Q3 2025. 26 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • LPL Financial held 40,795 shares of Black Diamond Therapeutics worth $75.5K as of Q2 2026.
  • LPL Financial sold 2,000 Black Diamond Therapeutics shares in Q2 2026, an estimated $4.89K.
  • Black Diamond Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5962 holding.
  • LPL Financial first reported a position in Black Diamond Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • LPL Financial's Black Diamond Therapeutics position peaked at $262K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.